TOP BUSINESS NEWS

Pune's swine flu vaccine 'Fluvac' to hit market in April-May Pune-based Indian medical firm The Serum Institute of India (SII) announced Monday that their swine flu vaccine 'Fluvac' would be available in the market by April-May 2010. ...
India Top Exporter Of Generic Medicines According to Srikanta Jena, Union Minister of State for Chemicals and Fertilisers, India has the world’s largest and most developed pharmaceutical industry, including being the top exporter of gener...
China welcomes Indian pharma firms after years of resistance Chinese health minister Chen Zhu said on Monday that Indian pharmaceutical companies were "more than welcome" to sell their products in China. The Indian companies have been complaining for a long tim...
Dept of pharma wants review of FDI rules The department of pharmaceuticals (DoP) under the ministry of chemicals and fertilisers has proposed that the government set up an expert group to assess the impact of foreign direct investment (FDI) ...
Zydus starts phase II and III trials for H1N1 Ahmedabad based pharma major Zydus Cadila has commenced the phase II and III of the clinical trials of its H1N1 vaccine as the first company in the country, while its competitors are close on its ...
How pharma can use deduction as addition? Pharmaceutical companies got a much sought-after wish granted when FM Pranab Mukherjee said in his Budget speech for 2010-11 that companies spending on in-house research and development will be ta...
Budget could push R&D spend by 25-50%: pharma players The R&D spend of drug companies could increase to the tune of 25 to 50 per cent thanks to the Budget push, feel Gujarat based pharma majors. This year's Union Budget has increased the weighted ded...
A Passage to India Dr Reddy’s has scaled down its global spread and wants to focus on its home market. Will it succeed? ...
200 pharma jobs for Dundalk Pharmaceutical giant Warner Chilcott is to create up to 200 high-skilled jobs with the establishment of a new headquarters in Dundalk, Co. Louth. ...
China calling Indian pharma Chinese delegates from the city of Wuxi arrived in Hyderabad today to showcase the vast investment opportunities their city presents and also to strengthen the economic ties between India and Chin...

EVENTS

HarNeedi.com, India’s No. 1 job portal for Healthcare and Pharma industry, will be organizing an exclusive ‘Healthi Job Fair 2010’ for Healthcare and Pharma 'Healthi Job Fair 2010' at the...

Pharmintech, the international exhibition for technology, materials and services for the processing and packaging of pharmaceutical, personal care and nutraceutical products is scheduled to take place at BolognaFiere from May...

Momentum is building for the early December staging in Mumbai of the third CPhI India and second P-MEC India pharma ingredients, services and technologies event. A combined total of over...

The fourth edition of the biotechnology investor forum, BioInvest 2009, organized by The Association of Biotechnology Led Entrepreneurs (ABLE) will be held in Mumbai on November 5. The event has...

Building on 8 years of success serving the pharmaceutical industry, Worldwide Business Research is proud to launch Logipharma as Asia's only dedicated conference for pharmaceutical supply chain professionals.

More in: International, National, Domestic

BIOTECHNOLOGY

Bangalore-based biopharmaceutical start-up Biovel Lifesciences is looking to exit from the life sciences space and is keen for an early outright buyout. Biovel has been in dialogue with several companies...

Sanofi-aventis, the world's leading vaccine manufacturer, officially launched the construction of a new Sanofi Pasteur vaccine manufacturing centre in Neuville-sur-Saône, France.

The pharmaceutical and biotechnology industry is in the process of consolidating and down-sizing while trying to maintain R&D productivity. Small and medium-sized companies are trying to make the most...

Last year, the Biotech industry as a whole achieved much better performance than the market. Both the NASDAQ Biotech Index and AMEX Biotech Index outperformed all three major market...

Lupin Ltd, one of the top five domestic pharmaceutical companies, plans to revamp its drug research programme and foray into novel biotech and reverse engineering of biotech drugs (or biosimilars)....

DEAL WATCH

Global pharma giant GlaxoSmithKline (GSK) is open to making acquisitions in India, Andrew Witty, chief executive officer said on Monday.

The acquisition by Merck KGaA, the world’s oldest pharmaceutical company, of US-based life sciences company Millipore Corporation, would create a business worth close to Rs 900 crore in India for...

Pharma firm Strides Arcolab today said it has entered into an agreement with South Africa-based Aspen to acquire the latters facility in Brazil for $75 million (nearly Rs. 343 crore)....

Valeant Pharmaceuticals International has entered into an agreement with Spear Pharmaceuticals, Inc. for rights to commercialize Refissa, a prescription-based topical tretinoin cream used to diminish fine wrinkles and fade irregular...

Nectar Lifesciences, a Rs 725 crore plus leading integrated pharma entity, has raised Rs 252 crore through preferential allotment of equity shares and Global Depository Receipts (GDR).

INDIAN PHARMA INDUSTRY

India Fast Expanding in Global Pharma Market - Exim Bank Study -- The Indian pharmaceutical industry today occupies a unique and fast expanding space in the global market ...

[English] [French] [Spanish]

Indian Pharmaceutical Industry poised for tremendous growth -- Today, India is recognized as one of the leading global players in pharmaceuticals. Driven by the knowledge skills,..

[English] [French] [Spanish]

COMPANY PROFILES

1.Indian Institute of Toxicology - Indian Institute of Toxicology (IIT) is one of the pioneers, independent Contract Research Organization (CRO) engaged in toxicology and has been in the business for the past 25 Years. The institute is committed to excellence, which is borne out of a State-of-art infrastructure & technical skills in the field of Toxicology Studies.... [English]-[French]-[Spanish]

EMERGING MARKETS

The collapse of the property market has left the economy with a huge hole that will be difficult to fill. One of the few sectors that offers hope of growth...

Lilliputs keep cropping up here and there, but can Gulliver be ignored?

Many shifting focus to emerging economies in struggle to stay afloatMajor Japanese pharmaceutical makers are expediting projects to construct plants and expand sales channels in emerging economies, such as China...

French drug manufacturing giant Sanofi-Aventis is stepping up its presence in the nonprescription drug market in the United States and Europe.

After East Europe and Mexico, Daiichi Sankyo, which bought out Ranbaxy Labs Ltd last year, is all set to leverage the latter’s marketing and distribution strength in six countries of...

PRODUCTS

Pharma major Ranbaxy Laboratories today said it has launched a new dermatological product Lulifin in the Indian market. This follows a strategic in-licensing agreement with Summit Pharmaceuticals International Corporation, Japan,...

DR REDDY’S Laboratories plans to buy brands in Russia and introduce new products in India as it plans to scale up businesses in key emerging markets, a top company executive...

Pharma major Ranbaxy Laboratories Limited today said it will launch a generic version of the urinary disorder treatment, Flomax, next year.

Brand ambassador Kajol Devgan promotes the kiss of good health. Expanding its footprint in India, Yakult Danone India (P) Ltd. announced its expansion by launching Yakult, a global probiotic health...

Sandoz today announced the introduction of tacrolimus capsules, a generic equivalent of Prograf®, in the US. Tacrolimus is an immunosuppressive treatment used to help prevent rejection of a kidney or...

CLINICAL TRIALS

Cadila Pharmaceuticals’ plan to indigenously develop Influenza A HINI (swine flu) vaccine in collaboration with US-based Novavax is likely to be delayed as the government has shown caution in giving...

Pharma major Dr Reddy’s Laboratories Ltd., (DRL), on Monday, announced results from the first phase III trials of its chemical entity, Balaglitazone, an insulin sensitizer used in the treatment of...

Pharma major Dr Reddy's Laboratories (DRL) is gearing up for taking its new anti-cholesterol drug to Phase II trials.

GE Healthcare announced the launch of FTA DMPK cards for the collection and storage of blood samples for use in pharmacokinetic and toxicokinetic (PK/TK) studies.

Ecron Acunova, a full-service clinical research organization (CRO), with offices across Europe, India and the US, has strengthened its Eastern European presence further by opening a new office in Moscow....

HEALTH CARE WATCH

Rheumatoid arthritis sufferers in England and Wales will gain access to an extra drug through the NHS to combat the condition.

Franchise India Holdings limited in association with Francorp and Medium Healthcare Consulting Pvt Ltd has organized a two day workshop on Business of Healthcare, Wellness and Beauty at Taj Lands...

Painkillers may help relieve pain, but as with most things, too much of the drugs is bad for health. Some learn it the hard way.

In what seems to be an alarming situation for the national health, India ranks highest in the list of Tuberculosis (TB) inflicted countries worldwide, as unveiled by the Union Ministry...

India's healthcare sector is expected to grow at 23 per cent annually to become a $77-billion industry by 2012, according to a recent report.

FDA

Aurobindo Pharma today said it has received a tentative approval from the US drug regulator for manufacturing and marketing of its Nevirapine tablets, used in the treatment of HIV infections....

Dishman Pharmaceuticals & Chemicals Ltd, a contract research & manufacturing services (CRAM) major, received the US Food and Drug Administration (USFDA) nod for producing Active Pharmaceutical Ingredients (API) at its...

Drug firm Sun Pharmaceutical Industries on Wednesday said that its subsidiary, has received US Drug regulator approval for anti-hypertension drug.

US-based Zydus Pharmaceuticals, a subsidiary of Zydus Cadila, has received final approval from the US Food and Drug Administration (USFDA) to market Ramipril tablets, in the strengths of 1.25 mg,...